CVS Group plc, a UK veterinary group, has responded to the Competition and Markets Authority's (CMA) review into the UK veterinary services market for household pets. The company states that it will support the CMA review and work closely with regulators. CVS's main focus is to provide the best possible care to animals, and it invests in its colleagues, practices, and clinical equipment to enhance this care. The company ensures that its pricing structures are set by clinicians to align with its purpose and reflect fair value to clients. CVS acknowledges the significant shortage of vets in the UK and states that employment costs represent the most significant proportion of its cost base. The company's pricing reflects this and other inflationary pressures experienced in recent years. CVS has a clear strategy to expand its network and improve clinical care through investment in facilities, equipment, technology, and its people. The company will announce its full-year results on September 21, 2023. CVS Group plc is an AIM-quoted fully-integrated provider of veterinary services in the UK, with practices in Australia, the Netherlands, and the Republic of Ireland. CVS operates c.500 veterinary practices across its four markets, including specialist referral hospitals and dedicated out-of-hours sites. In addition to veterinary practices, CVS also operates laboratories, crematoria, buying groups, and an online retail business called "Animed Direct."